Year: 2022

Continued expansion of the Senhance Program in the region RESEARCH TRIANGLE PARK, N.C., Dec. 29, 2022 (GLOBE NEWSWIRE) — Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that Kashiwa Kosei General Hospital in Kashiwa, Japan has entered into an agreement to lease and utilize a Senhance® Surgical System. “We are pleased to be partnering with another impressive institution as we continue to see high adoption rates in one of the fastest growing regions for Asensus,” said Anthony Fernando, Asensus Surgical President and CEO. “The recently approved thoracic indication will be a great addition to the Kashiwa Kosei General Hospital’s surgery department, and we look forward...

BEIJING, Dec. 29, 2022 (GLOBE NEWSWIRE) — Kingsoft Cloud Holdings Limited (“we,” “Kingsoft Cloud” or the “Company”) (NASDAQ: KC), a leading independent cloud service provider in China, today announced that the shareholders of the Company duly adopted all the resolutions proposed by the Company at its extraordinary general meeting of shareholders held in Beijing today, with high approval rate, paving way to Company’s proposed listing on Main Board of The Stock Exchange of Hong Kong Limited. Earlier on December 23, 2022, the Company announced the proposed dual primary listing of its ordinary shares, par value US$0.001 per share by way of introduction on the Main Board of The Stock Exchange of Hong Kong Limited. Subject to final listing approval from the SEHK, the Shares are expected to commence trading on the Main Board of the SEHK...

29 December 2022 CLEANTECH BUILDING MATERIALS PLC, NASDAQ FIRST NORTH GROWTH MARKET, COPENHAGEN TICKER:  CBMISIN: GBOOBD1LVD21 CLEANTECH BUILDING MATERIALS PLC DEBT CONVERSION AND ISSUE OF NEW SHARES Cleantech Building Materials PLC (“CBM” or the “Company”) announces that following the signature of the subscription agreement in July 2019 with a family office (the “Investor”) (the “Agreement”) it has reached an agreement with the Investor to convert €300,000 of outstanding debt under the Agreement at €1.25 per share into 240,000 new ordinary shares of £0.10 nominal par value each in the Company (“Ordinary Shares”), and for the new Ordinary Shares to be issued to the Investor (the “Conversion”). Following the Conversion the Investor will not hold 5% or more of the Company’s issued share capital. The Company will apply for the 240,000 new...

Bids, sales, stop-rates and prices are presented in the table below:      ISIN Bid Mill. kr. (nominal) Sale Stop-rate (per cent) Pro-rata Price98 18858 DKT 01/03/23 I 100 100 1.540 100 % 99.752598 18932 DKT 01/06/23 II 100 100 2.070 100 % 99.1449Total 200 200      The sale will settle 2 January 2023

TinyML AI Combined with LoRaWAN to Enable Ultralow Power, Long-Range Transmission and High-Performance AI for Indoor and Outdoor Utilization TAINAN, Taiwan and SHENZHEN, China , Dec. 29, 2022 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, and Seeed Studio, the IoT hardware partner providing services that empower developers to implement their projects and products for digital transformation, today announced the joint showcase of the SenseCAP A1101 LoRaWAN Vision AI Sensor, embedded with Himax WiseEye™ smart image sensing solution (“WiseEye”), at the upcoming CES 2023 from January 5 – 8, 2023 in Las Vegas, Nevada. Seeed Studio, with its tinyML Edge AI platform enabling expertise, has created...

Vancouver, BC, Dec. 29, 2022 (GLOBE NEWSWIRE) — Recharge Resources Ltd. (“Recharge” or the “Company”) (RR: CSE) (RECHF: OTC) (SL50: Frankfurt) is pleased to announce that Prospectair Geosurveys has finalized processing the high-resolution heliborne magnetic survey data collected from the company’s 100% owned Georgia Lake North and West Lithium Properties in Ontario, Canada (the “Property”). The Property is immediately contiguous to Rock Tech Lithium Inc’s (RCK–V) (“Rock Tech”) Georgia Lake Lithium Property and located approximately 160 km northeast of Thunder Bay, Ontario, within the Thunder Bay Mining Division. Recharge will be reviewing the data over the next month to implement a spring field program consisting of geological mapping and prospecting over target areas once conditions are favourable. CEO, David Greenway, stated,...

Successful Completion of USPTO Review Process for Company’s Lithium Extraction Patents VANCOUVER, British Columbia, Dec. 29, 2022 (GLOBE NEWSWIRE) — Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE American: SLI) (FRA: S5L), a leading near-commercial lithium company, is pleased to announce that the United States Patent and Trademark Office (“USPTO”) has issued a Notice of Allowance for Standard Lithium’s third U.S. patent application serial no. 16/895,783 titled “Process for Recovering Lithium from Brines”, This third U.S. patent application is in addition to Standard Lithium’s other two U.S. patent applications for which Notices of Allowance have been earlier issued by the USPTO (U.S. patent applications serial no.16/410,523 and serial no. 16/224/463, both also titled “Process for Recovering Lithium...

SHANGHAI, China, Dec. 29, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, today announces the online publication in New England Journal (NEJM) of the Phase 3 trial (NCT05341609) comparing the efficacy and safety of VV116 (JT001) and nirmatrelvir/ritonavir (“PAXLOVID”) in the treatment of symptomatic patients with mild to moderate COVID-19 who are at high risk for progression to severe COVID-19 including death. It is the first time that NEJM published the clinical trial results of China-developed anti-SARS-CoV-2 drug. The study, led by Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, is the first “head-to-head” phase...

SANTA CLARA, Calif., Dec. 28, 2022 (GLOBE NEWSWIRE) — Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that David Clapper, who has served as President and Chief Executive Officer since 2011, has chosen to retire. The Company’s board of directors (the Board) has appointed industry executive Todd Usen as President and Chief Executive Officer of Minerva Surgical and a member of the Board to succeed Mr. Clapper effective January 2, 2023. To ensure a smooth leadership transition, Mr. Clapper will continue to serve in his role through Mr. Usen’s first day of employment and has entered into a consulting agreement for 12 months following his retirement. “On behalf of the Board, the management team, and Minerva...